Home » Vertex to Buy Hepatitis C Drug Developer
Vertex to Buy Hepatitis C Drug Developer
Vertex Pharmaceuticals is adding two new drugs to its hepatitis C pipeline with the acquisition of ViroChem, a privately held Canadian drugmaker, the company announced.
TheStreet.com
TheStreet.com
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May